Strenght Training in Osteoporosis Prevention (SPORT)

Mateusz Karnia

Status

Active, not recruiting

Conditions

Osteopenia or Osteoporosis

Treatments

Dietary Supplement: Placebo

Dietary Supplement: Supplementation of vitamin D3

Study type

Interventional

Funder types

Other

Identifiers

NCT06733064

NdS-II/SP/0449/2024/0 (Other Grant/Funding Number)

Komisja Bioetyczna-47/23

Details and patient eligibility

About

The study involves 120 women over the age of 50.

All participants in the study take part in high-intensity strength training for 10 months.

In addition, half of the participants receive vitamin D3 at a dose of 4,000 IU/day.

The investigators hypothesize that training combined with vitamin D3 supplementation will be more effective in preventing osteoporosis than training alone.

Enrollment

120 patients

Sex

Female

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

age over 50
female

Exclusion criteria

ongoing cancer,
unstabilized cardiovascular disease,
cognitive disorders,
radiological treatment in the last 12 months,
other contraindications to undertaking high-intensity strength training,
diseases affecting the skeleton such as: Paget's disease, type I diabetes mellitus,
taking medications affecting skeletal conditions including: long-term therapy with corticosteroids, thiazides, antiretroviral drugs,
contraindications to taking vitamin D including: hypercalcemia, nephrolithiasis, sarcoidosis, lack of cholecalciferol hydroxylase activity in the liver and kidneys.